Cargando…

Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review

INTRODUCTION: Since 2007, many countries have implemented national human papillomavirus (HPV) vaccination programs with the quadrivalent HPV (4HPV) vaccine that has been shown to be efficacious in clinical trials involving 25,000 subjects. Two vaccine serotypes, HPV16 and 18, are responsible for cer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mariani, Luciano, Vici, Patrizia, Suligoi, Barbara, Checcucci-Lisi, Giovanni, Drury, Rosybel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311067/ https://www.ncbi.nlm.nih.gov/pubmed/25620536 http://dx.doi.org/10.1007/s12325-015-0178-4

Ejemplares similares

The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
por: Lukács, Anita, et al.
Publicado: (2020)

Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2015)

Correction: Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2016)

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males: Profile Report
por: Garnock-Jones, Karly P., et al.
Publicado: (2012)

Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada
por: Righolt, Christiaan H., et al.
Publicado: (2022)

Epidemiology of genital warts in the British population: implications for HPV vaccination programmes
por: Sonnenberg, Pam, et al.
Publicado: (2019)

Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study
por: Cocchio, Silvia, et al.
Publicado: (2017)

Prevalence and incidence of external genital warts in a sample of Italian general female population
por: Suligoi, Barbara, et al.
Publicado: (2017)

Recurrence of genitals warts in pre-HPV vaccine era after laser treatment
por: Widschwendter, Andreas, et al.
Publicado: (2019)

Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts
por: Díez-Domingo, Javier, et al.
Publicado: (2017)

HPV strain distribution in patients with genital warts in a female population sample
por: Boda, Daniel, et al.
Publicado: (2016)

Ongoing inadequacy of quadrivalent HPV vaccine safety studies
por: Little, Deirdre T, et al.
Publicado: (2020)

Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program
por: Ali, Hammad, et al.
Publicado: (2013)

Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study
por: Howell-Jones, Rebecca, et al.
Publicado: (2013)

HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients
por: Piñeros, Marion, et al.
Publicado: (2013)

Prevalence and distribution of HPV types in genital warts in Xi’an, China: a prospective study
por: Zhu, Cansheng, et al.
Publicado: (2019)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

HPV Vaccination Status and Resolution of Warts in Pediatric Patients
por: Burli, Anuk, et al.
Publicado: (2021)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine
por: Akuzum, Begum, et al.
Publicado: (2018)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
por: Tjon Pian Gi, Robin E. A., et al.
Publicado: (2016)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis
por: Denecke, Agnieszka, et al.
Publicado: (2021)

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
por: Smith, Megan A., et al.
Publicado: (2016)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines
por: Hartwig, Susanne, et al.
Publicado: (2015)

Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
por: Silling, Steffi, et al.
Publicado: (2014)

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Hammad, Noha M., et al.
Publicado: (2021)

Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
por: Östensson, Ellinor, et al.
Publicado: (2015)

Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance
por: Gomes, Jéssica Menezes, et al.
Publicado: (2020)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2018)

Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe
por: Hartwig, Susanne, et al.
Publicado: (2017)

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
por: Petry, Karl-Ulrich, et al.
Publicado: (2018)

Treatment of Pediatric Anogenital Warts in the Era of HPV-Vaccine: A Literature Review
por: Herzum, Astrid, et al.
Publicado: (2023)

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
por: Pinto, Ligia A., et al.
Publicado: (2016)

Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
por: Joshi, Smita, et al.
Publicado: (2023)

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
por: Paz-Zulueta, María, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t5jmfbseb1cbiqvtnnc385tjtu